
|Articles|October 25, 2012
Risk of VTE Increased in New Users of Drospirenone
A retrospective cohort study of more than a half million new users of hormonal contraception shows that drospirenone is associated with a higher risk of thrombotic events than contraceptives containing low-dose estrogen.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ayesha Dholakia, MD, discusses firearms as leading cause of US maternal death
2
Geographical disparities found in endometriosis guidance
3
Paracetamol use in pregnancy not clearly linked to autism or ADHD
4
Ultra-processed foods linked to early-onset colorectal cancer risk
5











